LifeSciences BC is governed by a Board of Directors, whose members represent British Columbia’s biopharmaceutical, biotechnology, medical devices, digital health and greater life sciences community. Our board provides guidance, sets policy and ensures that the organization operates effectively in achieving its mandate, which is to foster the economic development of B.C.’s life sciences industry.
Gordon McCauley – Partner, NDI Capital
James P. Hatton Q.C. – Partner, Technology Group, Farris, Vaughan, Wills & Murphy LLP
Doug Janzen – Founder & Managing Director, Northview Ventures
Ian Heine – Partner, PwC
Paul V. Drohan – President & CEO, LifeSciences BC
Dr. Brendan Byrne – VP & General Manager, Provider Solutions, TELUS Health
Robin Ciceri – President, The Research Universities’ Council of BC
Dr. Allen Eaves – President & CEO, STEMCELL Technologies Inc.
Nancy Harrison – Chief Business Officer, MSI Methylation Sciences Inc.
Alexei Marko – CEO & Director, Neovasc Inc.
Dr. Gavin Stuart – Dean, Faculty of Medicine, University of British Columbia
James Taylor – CEO, Precision Nanosystems Inc.
Dr. Paul Terry – President & CEO, PHEMI Health Systems
Dr. Alan E. Winter – President and CEO, Genome British Columbia
Observers to the Board
Joseph Garcia – Partner, Blake, Cassels & Graydon LLP
Hector MacKay-Dunn, J.D. Q.C. – Senior Partner, Farris, Vaughan, Wills & Murphy LLP